Skip to Content Facebook Feature Image

Empowering Central Asia's AI Ecosystem: TuringEra Debuts Full-Stack AI Appliances at GITEX AI Kazakhstan

Business

Empowering Central Asia's AI Ecosystem: TuringEra Debuts Full-Stack AI Appliances at GITEX AI Kazakhstan
Business

Business

Empowering Central Asia's AI Ecosystem: TuringEra Debuts Full-Stack AI Appliances at GITEX AI Kazakhstan

2026-05-06 20:00 Last Updated At:20:15

ALMATY, Kazakhstan, May 6, 2026 /PRNewswire/ -- TuringEra, a global leader in edge AI computing chips and full-stack solutions, successfully concluded a series of high-level commercial activities in Almaty this week. In addition to unveiling its "Cloud-Edge-End" AI appliance portfolio at GITEX AI Kazakhstan 2026, the company solidified its Central Asian expansion through strategic dialogues with regional industrial leaders and stakeholders.

Product Milestone: Redefining On-Premise and Edge AI

At GITEX AI, the TuringEra exhibit served as a hub for technical innovation, where the company launched three AI appliances designed to address the growing demand for localized computing and private deployment:

  1. Turing AI Appliance TLEV-8U100-70B: Engineered for enterprise-level privatization, powered by the proprietary U100 chip. It supports the local execution of 70B parameters models (such as Llama and Qwen), ensuring top-tier data security and regulatory compliance for high-stakes industries.
  2. Turing-DGX Spark: A desktop-grade AI supercomputer integrating the NVIDIA Grace Blackwell architecture. Delivering 1 PetaFLOP of performance, it enables research institutions and development teams to conduct real-time inference and fine-tuning of 200B parameter models in a compact form factor.
  3. Jetson W638 Appliance: A ruggedized Physical AI terminal based on the Jetson Blackwell platform. Designed for industrial environments (-20°C to 40°C), it brings 70B+ model reasoning to smart manufacturing, robotics, and UAVs at the edge.

During the event, President Kassym-Jomart Tokayev and other dignitaries visited the pavilion, noting the importance of international technical cooperation in advancing Kazakhstan's digital infrastructure.

Strategic Dialogue: Deepening Regional Integration

Beyond the exhibition, TuringEra engaged in intensive consultations to accelerate the localized adoption of AI:

  • Industrial Synergy: The team met with leading Kazakh mining groups, energy corporations, and robotics integrators. Discussions focused on deploying TuringEra's proprietary chips for autonomous mine inspections and intelligent energy management, resulting in several preliminary cooperation agreements for scenario-based applications.
  • Institutional Engagement: TuringEra held productive exchanges with the Ministry of Digital Development, Innovations and Aerospace Industry, the Almaty Mayor's Office, and Kazakh Invest. The company expressed its intent to utilize Almaty as a strategic hub for Central Asia, contributing to the "Digital Kazakhstan" initiative through infrastructure investment and local talent cultivation. In addition, the TuringEra team held discussions with senior officials from the Uzbekistan government. Both parties expressed a strong mutual interest in collaborating on AI computing infrastructure, Smart City initiatives, and industrial digitalization.

With an established presence in Canada, Dubai, Japan, and South Korea, this move into Kazakhstan marks a significant milestone in TuringEra's global roadmap.

Future Outlook: A Four-Phase Localization Roadmap

"Kazakhstan is entering a golden age of digital and AI transformation," stated Qu Hao, President of TuringEra, during interviews with national media outlets Qazaqstan and Khabar TV. "We are here not just to exhibit, but to deliver a long-term commitment. By combining our technical prowess with localized service, we aim to be the most reliable partner for AI computing infrastructure in Central Asia."

TuringEra's regional roadmap includes:

  1. Local Operations: Establishing an Almaty office and recruiting local engineering and sales teams.
  2. Sector Focus: Targeting AI integration in public services, autonomous mining, and industrial robotics.
  3. Vertical Expansion: Deepening AI applications in healthcare imaging and "lights-out" automated factories.
  4. Supply Chain Resilience: Exploring local assembly facilities as market demand scales to enhance delivery efficiency.

About TuringEra

TuringEra is a global technology company specializing in AI computing chips and full-stack solutions across cloud, edge, and terminal scenarios. With a core focus on "Compute, Storage, Power, and Connectivity" (CSPC) innovation, TuringEra provides comprehensive systems for robotics, UAVs, and intelligent data centers, maintaining deep strategic partnerships with global leaders such as NVIDIA.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Empowering Central Asia's AI Ecosystem: TuringEra Debuts Full-Stack AI Appliances at GITEX AI Kazakhstan

Empowering Central Asia's AI Ecosystem: TuringEra Debuts Full-Stack AI Appliances at GITEX AI Kazakhstan

Kaneka Ubiquinol's 'Flexibility in Formulation' innovation partnership philosophy driving world-class award-winning results

Ubiquinol-powered Mitochondrial Health moves front and centre across food, nutraceutical and beverage formulations worldwide as consumer demand accelerates for cellular health solutions

BARCELONA, Spain, May 6, 2026 /PRNewswire/ -- Kaneka Ubiquinol™, the sole global innovative manufacturer and pioneer of Ubiquinol, and inaugural Mitochondrial Health Category Sponsor at Vitafoods Europe 2026, announced today that it has been awarded the coveted Vitafoods Europe Innovation Award 2026 in the Most Innovative Consumer-Ready Nutraceutical Finished Product category in partnership with Eqology Pure Arctic Oil Heart & Energy.

A first of its kind, the category-defining formulation, Pure Arctic Oil Heart & Energy combines sustainable CodMarine® Arctic cod liver oil, organic cold-pressed extra virgin olive oil, vitamin D3 and Kaneka Ubiquinol™.

Backed by robust science, the formulation has been shown to support cardiovascular and cellular energy health, with validated oxidative stability[i]. Its dual-use functionality, supplement and culinary oil, exemplifies true formulation flexibility enabling easy integration into daily healthy eating protocols – uniting marine purity, Mediterranean phytonutrients and mitochondrial science into one clinically credible, sustainable solution, that presents a unique and tasty nutritional oil or dressing to enhance healthy lifestyle eating.

At the heart of this trailblazing innovation is Kaneka Ubiquinol™ – the more bioactive form of coenzyme Q10, which plays an essential role in mitochondrial energy production and antioxidant protection.

With mitochondria generating approximately 90% of the body's energy[ii] and natural ubiquinol levels declining from age 20+[iii], supporting mitochondrial energy production is increasingly recognised as important for cardiovascular health, reproductive health, women's health, cognitive function and healthy ageing.

Marking the prestigious award Kaneka EU GM, Filip Van hulle said, "This significant achievement drives our commitment to push further in innovation – partnering with brandholders with world-class science and expertise to co-create products that drive true innovation in mitochondrial health".

ABOUT KANEKA UBIQUINOL™

Kaneka Corporation is the award-winning sole global innovative manufacturer of clinically proven bioidentical ubiquinol, via an award-winning Japanese natural fermentation process. Supported by 100+ studies, 80+ patents and 45+ years of research across cardiovascular health, cognition, women's health, reproduction and energy. Listed in 50+ countries in 1,000+ nutraceutical brands since 2006, with certifications including HALAL, GRAS, HACCP, NDI, KOSHER, GMP, ISO 14001, ISO 22000, Non-GMO and OSHMS.

WEBSITE: www.kaneka-ubiquinol.com

[i] Eqology/Pharma Marine. Certificate of Analysis: Oxidative Stability Index of Pure Arctic Oil Heart & Energy. Internal method AM29 based on Rancimat method and AOCS Cd 12b-92. October 2025.

Kaneka Corporation. Kaneka Ubiquinol™ Technical Guide. Supplement Strategic Unit, Pharma & Supplemental Nutrition SV, Kaneka Corporation. 2024/2025.

[ii] Reynolds S. Mitochondria and health. NIH 2025.Nolfi-Donegan D, et al. Mitochondrial electron transport chain. Redox Biol 2020.

[iii] Kalén A, et al. Age-related changes in the lipid compositions of rat and human tissues. Lipids 1989;24(7):579-584.

Wada H, et al. Redox status of coenzyme Q10 is associated with chronological age. JAGS. 2007;55:1141-1142.

 



Kaneka Ubiquinol's 'Flexibility in Formulation' innovation partnership philosophy driving world-class award-winning results

Ubiquinol-powered Mitochondrial Health moves front and centre across food, nutraceutical and beverage formulations worldwide as consumer demand accelerates for cellular health solutions

BARCELONA, Spain, May 6, 2026 /PRNewswire/ -- Kaneka Ubiquinol™, the sole global innovative manufacturer and pioneer of Ubiquinol, and inaugural Mitochondrial Health Category Sponsor at Vitafoods Europe 2026, announced today that it has been awarded the coveted Vitafoods Europe Innovation Award 2026 in the Most Innovative Consumer-Ready Nutraceutical Finished Product category in partnership with Eqology Pure Arctic Oil Heart & Energy.

A first of its kind, the category-defining formulation, Pure Arctic Oil Heart & Energy combines sustainable CodMarine® Arctic cod liver oil, organic cold-pressed extra virgin olive oil, vitamin D3 and Kaneka Ubiquinol™.

Backed by robust science, the formulation has been shown to support cardiovascular and cellular energy health, with validated oxidative stability[i]. Its dual-use functionality, supplement and culinary oil, exemplifies true formulation flexibility enabling easy integration into daily healthy eating protocols – uniting marine purity, Mediterranean phytonutrients and mitochondrial science into one clinically credible, sustainable solution, that presents a unique and tasty nutritional oil or dressing to enhance healthy lifestyle eating.

At the heart of this trailblazing innovation is Kaneka Ubiquinol™ – the more bioactive form of coenzyme Q10, which plays an essential role in mitochondrial energy production and antioxidant protection.

With mitochondria generating approximately 90% of the body's energy[ii] and natural ubiquinol levels declining from age 20+[iii], supporting mitochondrial energy production is increasingly recognised as important for cardiovascular health, reproductive health, women's health, cognitive function and healthy ageing.

Marking the prestigious award Kaneka EU GM, Filip Van hulle said, "This significant achievement drives our commitment to push further in innovation – partnering with brandholders with world-class science and expertise to co-create products that drive true innovation in mitochondrial health".

ABOUT KANEKA UBIQUINOL™

Kaneka Corporation is the award-winning sole global innovative manufacturer of clinically proven bioidentical ubiquinol, via an award-winning Japanese natural fermentation process. Supported by 100+ studies, 80+ patents and 45+ years of research across cardiovascular health, cognition, women's health, reproduction and energy. Listed in 50+ countries in 1,000+ nutraceutical brands since 2006, with certifications including HALAL, GRAS, HACCP, NDI, KOSHER, GMP, ISO 14001, ISO 22000, Non-GMO and OSHMS.

WEBSITE: www.kaneka-ubiquinol.com

[i] Eqology/Pharma Marine. Certificate of Analysis: Oxidative Stability Index of Pure Arctic Oil Heart & Energy. Internal method AM29 based on Rancimat method and AOCS Cd 12b-92. October 2025.

Kaneka Corporation. Kaneka Ubiquinol™ Technical Guide. Supplement Strategic Unit, Pharma & Supplemental Nutrition SV, Kaneka Corporation. 2024/2025.

[ii] Reynolds S. Mitochondria and health. NIH 2025.Nolfi-Donegan D, et al. Mitochondrial electron transport chain. Redox Biol 2020.

[iii] Kalén A, et al. Age-related changes in the lipid compositions of rat and human tissues. Lipids 1989;24(7):579-584.

Wada H, et al. Redox status of coenzyme Q10 is associated with chronological age. JAGS. 2007;55:1141-1142.

 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Kaneka Ubiquinol™ Wins Coveted Vitafoods Europe Innovation Award 2026 in Partnership with Eqology

Kaneka Ubiquinol™ Wins Coveted Vitafoods Europe Innovation Award 2026 in Partnership with Eqology

Kaneka Ubiquinol™ Wins Coveted Vitafoods Europe Innovation Award 2026 in Partnership with Eqology

Kaneka Ubiquinol™ Wins Coveted Vitafoods Europe Innovation Award 2026 in Partnership with Eqology

Recommended Articles